Novaccess Global Inc (XSNX)
0.0065
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Novaccess Global 1 Year Total Returns (Daily): -96.39% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -96.39% |
May 02, 2024 | -94.66% |
May 01, 2024 | -95.14% |
April 30, 2024 | -94.33% |
April 29, 2024 | -95.54% |
April 26, 2024 | -96.09% |
April 25, 2024 | -96.17% |
April 24, 2024 | -95.51% |
April 23, 2024 | -94.87% |
April 22, 2024 | -95.51% |
April 19, 2024 | -94.90% |
April 18, 2024 | -94.70% |
April 17, 2024 | -94.97% |
April 16, 2024 | -95.50% |
April 15, 2024 | -94.44% |
April 12, 2024 | -93.97% |
April 11, 2024 | -94.42% |
April 10, 2024 | -92.95% |
April 09, 2024 | -91.99% |
April 08, 2024 | -91.35% |
April 05, 2024 | -93.46% |
April 04, 2024 | -94.47% |
April 03, 2024 | -93.72% |
April 02, 2024 | -93.37% |
April 01, 2024 | -93.37% |
Date | Value |
---|---|
March 28, 2024 | -94.29% |
March 27, 2024 | -95.36% |
March 26, 2024 | -93.43% |
March 25, 2024 | -93.43% |
March 22, 2024 | -93.43% |
March 21, 2024 | -95.36% |
March 20, 2024 | -95.74% |
March 19, 2024 | -95.15% |
March 18, 2024 | -94.94% |
March 15, 2024 | -92.29% |
March 14, 2024 | -92.55% |
March 13, 2024 | -91.73% |
March 12, 2024 | -92.29% |
March 11, 2024 | -92.29% |
March 08, 2024 | -92.89% |
March 07, 2024 | -93.32% |
March 06, 2024 | -92.11% |
March 05, 2024 | -90.47% |
March 04, 2024 | -87.92% |
March 01, 2024 | -86.50% |
February 29, 2024 | -86.50% |
February 28, 2024 | -88.89% |
February 27, 2024 | -83.55% |
February 26, 2024 | -86.05% |
February 23, 2024 | -89.40% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-96.39%
Minimum
May 03 2024
320.0%
Maximum
Jul 14 2021
-27.62%
Average
-40.00%
Median
May 09 2019
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -27.23% |
AIM ImmunoTech Inc | -15.65% |
IGC Pharma Inc | 53.98% |
NovaBay Pharmaceuticals Inc | -90.79% |
Protalix BioTherapeutics Inc | -63.81% |